Document is current

Article History

Received: 20 November 2024

Accepted: 25 April 2025

First Online: 6 May 2025

Declarations

:

: The study was approved by Institutional Review Board of Kangwon National University (KWNUIRB-2023-04-007-001, Chuncheon, South Korea) and the trial was retrospectively registered in the International Clinical Trial Registry Platform (ICTRP) (registration date: 17/07/2023; registration number: KCT0008626). Additionally, this study involved human subjects and/or human data and adhered to the Declaration of Helsinki (). Included patients received written as well as verbal information about the study protocol and signed an informed consent form before initiating the study.

: Not applicable.

: The authors declare no competing interests.